ERBB2 and breast carcinoma: Secondly, MAPK, MicroRNAs, FoxO, and HIF-1 signal pathway genes are enriched in large numbers, which are the key pathways for THSWD to treat HER-2 positive breast cancer, as shown in Fig. 9.